Halaven® (Eribulin) Remains Available for Patients with Advanced Metastatic Breast Cancer Who Have Progressed After at Least Two Chemotherapeutic Regimens Despite Recent NICE Draft Guidance in an Earlier Setting

HATFIELD, England, November 30, 2017 /PRNewswire/ -- The availability of Halaven® (eribulin) for the treatment of adults with locally advanced or metastatic breast cancer who have progressed after at least two chemotherapeutic regimens[1] remains unaffected even though recent draft...

from PR Newswire: //www.prnewswire.co.uk/news-releases/halaven-eribulin-remains-available-for-patients-with-advanced-metastatic-breast-cancer-who-have-661044473.html